Association of anti-smoking legislation with rates of hospital admission for cardiovascular and respiratory conditions.
BACKGROUND
Few studies have examined the impact of anti-smoking legislation on respiratory or cardiovascular conditions other than acute myocardial infarction. We studied rates of hospital admission attributable to three cardiovascular conditions (acute myocardial infarction, angina, and stroke) and three respiratory conditions (asthma, chronic obstructive pulmonary disease, and pneumonia or bronchitis) after the implementation of smoking bans.


METHODS
We calculated crude rates of admission to hospital in Toronto, Ontario, from January 1996 (three years before the first phase of a smoking ban was implemented) to March 2006 (two years after the last phase was implemented. We used an autoregressive integrated moving-average (ARIMA) model to test for a relation between smoking bans and admission rates. We compared our results with similar data from two Ontario municipalities that did not have smoking bans and with conditions (acute cholecystitis, bowel obstruction and appendicitis) that are not known to be related to second-hand smoke.


RESULTS
Crude rates of admission to hospital because of cardiovascular conditions decreased by 39% (95% CI 38%-40%) and admissions because of respiratory conditions decreased by 33% (95% CI 32%-34%) during the ban period affecting restaurant settings. No consistent reductions in these rates were evident after smoking bans affecting other settings. No significant reductions were observed in control cities or for control conditions.


CONCLUSIONS
Our results serve to expand the list of health outcomes that may be ameliorated by smoking bans. Further research is needed to establish the types of settings in which smoking bans are most effective. Our results lend legitimacy to efforts to further reduce public exposure to tobacco smoke.
Naiman
Alisa
A
Department of Family and Community Medicine, University of Toronto, Ont. a.naiman@utoronto.ca
Glazier
Richard H
RH
Moineddin
Rahim
R
D000328:Adult; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000453:epidemiology*; D008297:Male; D009864:Ontario / Q000453:epidemiology; D010343:Patient Admission / Q000706:statistics & numerical data* / Q000639:trends; D012907:Smoking / Q000331:legislation & jurisprudence*; D012926:Social Control, Formal; D014028:Tobacco Smoke Pollution / Q000331:legislation & jurisprudence / Q000517:prevention & control
D014028:Tobacco Smoke Pollution
Eur Heart J. 2006 Oct;27(20):2468-72
16940340
Chest. 1994 Sep;106(3):746-9
8082352
Lancet. 2006 Aug 19;368(9536):647-58
16920470
Prev Med. 2007 Jul;45(1):3-8
17482249
N Engl J Med. 2008 Jul 31;359(5):482-91
18669427
N Engl J Med. 2007 Apr 12;356(15):1496-8
17429081
Hum Exp Toxicol. 2001 Feb;20(2):61-83
11327513
Chest. 2002 Sep;122(3):1086-90
12226059
Circulation. 2008 Mar 4;117(9):1183-8
18268149
BMJ. 2004 Apr 24;328(7446):977-80
15066887
Circulation. 2006 Oct 3;114(14):1490-6
17000911
Am J Public Health. 2007 Nov;97(11):2035-9
17901438
Thorax. 2005 Oct;60(10):814-21
16192366
Am J Med. 2004 Feb 1;116(3):145-50
14749157
JAMA. 1998 Dec 9;280(22):1909-14
9851475
Thorax. 1998 May;53(5):381-7
9708231